1. Home
  2. ALK vs AXSM Comparison

ALK vs AXSM Comparison

Compare ALK & AXSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALK
  • AXSM
  • Stock Information
  • Founded
  • ALK 1932
  • AXSM 2012
  • Country
  • ALK United States
  • AXSM United States
  • Employees
  • ALK N/A
  • AXSM N/A
  • Industry
  • ALK Air Freight/Delivery Services
  • AXSM Biotechnology: Pharmaceutical Preparations
  • Sector
  • ALK Consumer Discretionary
  • AXSM Health Care
  • Exchange
  • ALK Nasdaq
  • AXSM Nasdaq
  • Market Cap
  • ALK 6.6B
  • AXSM 5.9B
  • IPO Year
  • ALK N/A
  • AXSM 2015
  • Fundamental
  • Price
  • ALK $42.83
  • AXSM $138.49
  • Analyst Decision
  • ALK Strong Buy
  • AXSM Strong Buy
  • Analyst Count
  • ALK 12
  • AXSM 20
  • Target Price
  • ALK $72.17
  • AXSM $176.00
  • AVG Volume (30 Days)
  • ALK 3.7M
  • AXSM 518.0K
  • Earning Date
  • ALK 10-23-2025
  • AXSM 11-03-2025
  • Dividend Yield
  • ALK N/A
  • AXSM N/A
  • EPS Growth
  • ALK N/A
  • AXSM N/A
  • EPS
  • ALK 1.23
  • AXSM N/A
  • Revenue
  • ALK $14,141,000,000.00
  • AXSM $561,263,000.00
  • Revenue This Year
  • ALK $22.78
  • AXSM $63.66
  • Revenue Next Year
  • ALK $7.24
  • AXSM $54.46
  • P/E Ratio
  • ALK $35.03
  • AXSM N/A
  • Revenue Growth
  • ALK 31.50
  • AXSM 65.83
  • 52 Week Low
  • ALK $39.79
  • AXSM $75.56
  • 52 Week High
  • ALK $78.08
  • AXSM $141.36
  • Technical
  • Relative Strength Index (RSI)
  • ALK 40.40
  • AXSM 69.20
  • Support Level
  • ALK $39.82
  • AXSM $123.50
  • Resistance Level
  • ALK $42.45
  • AXSM $141.36
  • Average True Range (ATR)
  • ALK 1.59
  • AXSM 5.19
  • MACD
  • ALK 0.06
  • AXSM 0.36
  • Stochastic Oscillator
  • ALK 33.87
  • AXSM 83.90

About ALK Alaska Air Group Inc.

Alaska Air Group Inc operates two airlines, Alaska and Horizon in three operating segments. The Alaska Airlines segment includes scheduled air transportation on Alaska's Boeing and Airbus jet aircraft for passengers and cargo throughout the U.S., and in parts of Mexico, and Costa Rica. The Regional segment includes Horizon's and other third-party carriers' scheduled air transportation for passengers across a shorter distance network within the U.S. and Canada under capacity purchase agreements (CPA). The Hawaiian Airlines segment includes scheduled air transportation on Hawaiian's Boeing and Airbus aircraft for passengers and cargo. It earns revenues from Passenger tickets, including ticket breakage and net of taxes and fees, Passenger ancillary and Mileage Plan passenger revenue.

About AXSM Axsome Therapeutics Inc.

Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.

Share on Social Networks: